Medicines optimisation: from principles to practice


About this event

About this event

Medicines remain the most common therapeutic intervention in health care, but evidence shows that the system does not achieve full value from its medicines, and unfortunately a high proportion are not used correctly and/or are subsequently wasted. 

This free-to-attend seminar built on the findings of our report, Polypharmacy and medicines optimisation: making it safe and sound, and other recent work including the Royal Pharmaceutical Society report on medicines optimisation.

Hear from the speakers at this event

Featuring in this video are:

  • Dr Keith Ridge, Chief Pharmaceutical Officer, NHS England
  • Martin Duerden, Deputy Medical Director, Betsi Cadwaladr Health Board
  • Paula Tully, Head of Customer and Channel Marketing, Established Products, Pfizer.

The seminar was chaired by Dr David Oliver, Visiting Fellow at The King’s Fund, and President Elect of the British Geriatric Society.

The seminar was organised jointly with Pfizer, through The King’s Fund's Corporate Partnerships Programme.